Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

MAGNETISMM-4 A Phase 1b/2, Open Label Umbrella Study of Elranatamab (PF-06863135), a B-Cell Maturation Antigen (BCMA) CD3 Bispecific Antibody, in Combination with Other Anti-Cancer Treatments in Participants with Multiple Myeloma


Collapse Overview 
Collapse sponsor award id
UAMS25065


Collapse Biography 

Collapse Time 
Collapse start date
2022-12-19

Collapse end date
2023-12-18